Winston-Salem.

PositionTriad

WINSTON-SALEM -- Targacept struck a licensing deal with London-based drug maker AstraZeneca for a depression treatment. The agreement could pay Targacept $1.2 billion and help it stay independent (Regional Report, December).

For a daily roundup of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT